Alnylam Pharmaceuticals
ALNY
#434
Rank
$53.43 B
Marketcap
$404.46
Share price
-2.59%
Change (1 day)
59.29%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company